Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LSXMA
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -11.81 0.31 0.35
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 14.21 18.69 16.36
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.21 31.63 30.95
Cash 60.52 1.50 0.93
Capex -34.45 -0.53 -0.40
Free Cash Flow -77.28 0.28 1.21
Revenue -5.08 6.61 6.97
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.41 0.48 0.50
Operating Margin -4.87 0.19 0.20
ROA 11.63 < 0.005 < 0.005
ROE 13.05 0.02 0.02
ROIC -23.74 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LSXMA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LSXMA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LSXMA is permitted for members.